SCOPUS 정보 검색 플랫폼

Volumn 69, Issue 11-12, 2009, Pages 1211-1220

Identification, isolation, and characterization of five potential degradation impurities in candesartan cilexetil tablets

(5) Mohan, Arivozhi a Shanmugavel, S a Goyal, Ajay a Venkataraman, B R b Saravanan, D c

a Torrent Pharmaceuticals Ltd (India)

b Periyar EVR College (India)

c NATIONAL COLLEGE (India)

Author keywords

Candesartan cilexetil degradation products; Column liquid chromatography mass spectrometry; NMR spectroscopy

Indexed keywords

1N ETHYLCANDESARTAN CILEXETIL; 1N ETHYLOXOCANDESARTAN CILEXETIL; 2N ETHYLCANDESARTAN CILEXETIL; 2N ETHYLOXOCANDESARTAN CILEXETIL; CANDESARTAN HEXETIL; DEETHYLCANDESARTAN CILEXETIL; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DRUG DEGRADATION; DRUG IMPURITY; ELECTROSPRAY MASS SPECTROMETRY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 67649995812 PISSN: 00095893 EISSN: 16121112 Source Type: Journal
DOI: 10.1365/s10337-009-1066-3 Document Type: Article

Times cited : (14)

References (11)

1
- 67649934187
- Y Michihiro Y Hirofumi 2000 Clin Pharmacol 93 175 182
- (2000) Clin Pharmacol , vol.93 , pp. 175-182
- Michihiro, Y.¹ Hirofumi, Y.²

2
- 0032442218
- 10.1023/A:1007754100351
- M Kenichi I Shinji M Keiko E Shigeru T Masayuki O Mamoru S Hideki K Masahiko 1998 Cardiovasc Drugs Ther 12 469 474 10.1023/A:1007754100351
- (1998) Cardiovasc Drugs Ther , vol.12 , pp. 469-474
- Kenichi, M.¹ Shinji, I.² Keiko, M.³ Shigeru, E.⁴ Masayuki, T.⁵ Mamoru, O.⁶ Hideki, S.⁷ Masahiko, K.⁸

3
- 67650002495
- www.Rxlist.com

4
- 0032810866
- 10.1016/S0378-4347(99)00247-9
- H Stenhoff P-O Lagerström C Andersen 1999 J Chromatogr B Analyt Technol Biomed Life Sci 731 411 417 10.1016/S0378-4347(99)00247-9
- (1999) J Chromatogr B Analyt Technol Biomed Life Sci , vol.731 , pp. 411-417
- Stenhoff, H.¹ Lagerström, P.-O.² Andersen, C.³

5
- 34547681630
- 10.1016/j.jchromb.2007.04.009
- N Ferreirós S Dresen RM Alonso W Weinmann 2007 J Chromatogr B Analyt Technol Biomed Life Sci 855 134 138 10.1016/j.jchromb.2007.04.009
- (2007) J Chromatogr B Analyt Technol Biomed Life Sci , vol.855 , pp. 134-138
- Ferreirós, N.¹ Dresen, S.² Alonso, R.M.³ Weinmann, W.⁴

6
- 34848833202
- 10.1365/s10337-007-0364-x
- DV Subba Rao P Radhakrishnanand MV Suryanarayana V Himabindu 2007 Chromatographia 66 499 507 10.1365/s10337-007-0364-x
- (2007) Chromatographia , vol.66 , pp. 499-507
- Subba Rao, D.V.¹ Radhakrishnanand, P.² Suryanarayana, M.V.³ Himabindu, V.⁴

7
- 67649999326
- Impurities in New Drug Substances Q3A (R2)
- International Conference on Harmonization guideline (2006) Impurities in New Drug Substances Q3A (R2)
- (2006) International Conference on Harmonization Guideline

8
- 67649934185
- Impurities in New Drug products Q3B (R2)
- International Conference on Harmonization guideline (2006) Impurities in New Drug products Q3B (R2)
- (2006) International Conference on Harmonization Guideline

9
- 0003228192
- ICH guidelines on validation of analytical procedures: Text and methodology Q2 (R1): FDA
- International Conference on Harmonization
- International Conference on Harmonization 1995 ICH guidelines on validation of analytical procedures: text and methodology Q2 (R1): FDA Fed Regist 60 11260
- (1995) Fed Regist , vol.60 , pp. 11260

10
- 84861563838
- WO 2006/122254 A2
- Kurgan Z, Pesachovich M (2006) World intellectual property organization, WO 2006/122254 A2
- (2006) World Intellectual Property Organization
- Kurgan, Z.¹ Pesachovich, M.²

11
- 21144478938
- 10.1007/BF00810934
- W Holzer C Jäger 1992 Monatsh Chem 123 1027 1036 10.1007/BF00810934
- (1992) Monatsh Chem , vol.123 , pp. 1027-1036
- Holzer, W.¹ Jäger, C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.